Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer

NCT00147537 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

282

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: CP-751,871
DRUG: paclitaxel
DRUG: carboplatin
DRUG: CP-751,871
DRUG: paclitaxel
DRUG: carboplatin
DRUG: erlotinib

Sponsor

Pfizer